Pay in 4 interest-free payments of $5.34 Learn more
Ships within 48 hours · Estimated delivery Aug 13 - Aug 18
(Nasdaq: IMVT), a clinical-stage immunology company dedicated to enabling normal lives for people with autoimmune diseases, today announced that subcutaneously administered doses of IMVT-1402 produced dose-dependent reductions in IgG in initial data from a Phase 1 clinical trial in healthy adults, with no dose-related changes in serum albumin or LDL-C, bolstering IMVT-1402 as a potential best-in-class neonatal fragment crystallizable receptor (FcRn) inhibitor
Make sleep a priority.Tips & Tricks
Prioritize seven to eight hours nightly during the first three months of treatment
Healthcare professionals should investigate such symptoms promptly to determine their cause
Emcure news: Emcure slashed the price of Poviztra (semaglutide injection) by 55%
WHAT DOES THE SOFWAVE TREATMENT FEEL LIKE
:max_bytes(150000):strip_icc()/Health-GettyImages-2236560849-a1934f1e4c004a19835cb508d021388b.jpg)
US$ 22.27
US$ 23.27
US$ 27.57
US$ 23.39
